Opko Health Inc. Announces New Compensation Plan Granting Stock Options and Bonuses to Executive Officers

Reuters

2025/05/30

<a href="https://laohu8.com/S/OPK">Opko Health</a> Inc. Announces New Compensation Plan Granting Stock Options and Bonuses to Executive Officers

Opko Health Inc. announced new compensation terms for its executive officers following a meeting of the company's Compensation Committee on May 27, 2025. The company granted stock options and approved bonus payments for its top executives. Phillip Frost, M.D., the CEO and Chairman, received 500,000 stock options with an exercise price of $1.31 per share and a bonus of $480,000. Vice Chairman and Chief Technical Officer, Jane H. Hsiao, Ph.D., and Vice Chairman and President, Elias A. Zerhouni, M.D., each received 500,000 stock options and a bonus of $450,000. Executive Vice President Steven D. Rubin was awarded 437,500 stock options and a $400,000 bonus, while Senior Vice President and CFO Adam Logal received the same number of stock options and a $475,000 bonus. The options vest annually over four years and expire ten years from the grant date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opko Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-079098), on May 29, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2539296415"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2539296415\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2539296415?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-30 05:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2539296415","market":"us","top_or_hot":-1,"title":"Opko Health Inc. Announces New Compensation Plan Granting Stock Options and Bonuses to Executive Officers","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/OPK\">Opko Health</a> Inc. Announces New Compensation Plan Granting Stock Options and Bonuses to Executive Officers\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Opko Health Inc. announced new compensation terms for its executive officers following a meeting of the company's Compensation Committee on May 27, 2025. The company granted stock options and approved bonus payments for its top executives. Phillip Frost, M.D., the CEO and Chairman, received 500,000 stock options with an exercise price of $1.31 per share and a bonus of $480,000. Vice Chairman and Chief Technical Officer, Jane H. Hsiao, Ph.D., and Vice Chairman and President, Elias A. Zerhouni, M.D., each received 500,000 stock options and a bonus of $450,000. Executive Vice President Steven D. Rubin was awarded 437,500 stock options and a $400,000 bonus, while Senior Vice President and CFO Adam Logal received the same number of stock options and a $475,000 bonus. The options vest annually over four years and expire ten years from the grant date.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opko Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-079098), on May 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Opko Health Inc. Announces New Compensation Plan Granting Stock Options and Bonuses to Executive Officers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOpko Health Inc. Announces New Compensation Plan Granting Stock Options and Bonuses to Executive Officers\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-30 05:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/OPK\">Opko Health</a> Inc. Announces New Compensation Plan Granting Stock Options and Bonuses to Executive Officers\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Opko Health Inc. announced new compensation terms for its executive officers following a meeting of the company's Compensation Committee on May 27, 2025. The company granted stock options and approved bonus payments for its top executives. Phillip Frost, M.D., the CEO and Chairman, received 500,000 stock options with an exercise price of $1.31 per share and a bonus of $480,000. Vice Chairman and Chief Technical Officer, Jane H. Hsiao, Ph.D., and Vice Chairman and President, Elias A. Zerhouni, M.D., each received 500,000 stock options and a bonus of $450,000. Executive Vice President Steven D. Rubin was awarded 437,500 stock options and a $400,000 bonus, while Senior Vice President and CFO Adam Logal received the same number of stock options and a $475,000 bonus. The options vest annually over four years and expire ten years from the grant date.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opko Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-079098), on May 29, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL6btpBx:1","article_id":"2539296415","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2539296415","pubTimestamp":1748552465,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Opko Health Inc. announced new compensation terms for its executive officers following a meeting of the company's Compensation Committee on May 27, 2025. The company granted stock options and approved bonus payments for its top executives. Phillip Frost, M.D., the CEO and Chairman, received 500,000 stock options with an exercise price of $1.31 per share and a bonus of $480,000. Vice Chairman and Chief Technical Officer, Jane H. Hsiao, Ph.D., and Vice Chairman and President, Elias A. Zerhouni, M.D., each received 500,000 stock options and a bonus of $450,000. Executive Vice President Steven D. Rubin was awarded 437,500 stock options and a $400,000 bonus, while Senior Vice President and CFO Adam Logal received the same number of stock options and a $475,000 bonus. The options vest annually over four years and expire ten years from the grant date.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","OPK":"Opko Health","BK4196":"保健护理服务"},"translate_title":"Opko Health Inc.宣布新的薪酬计划，向高管授予股票期权和奖金","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPK":0.9},"content_text":"Opko Health Inc. Announces New Compensation Plan Granting Stock Options and Bonuses to Executive Officers\n    \n\n        Opko Health Inc. announced new compensation terms for its executive officers following a meeting of the company's Compensation Committee on May 27, 2025. The company granted stock options and approved bonus payments for its top executives. Phillip Frost, M.D., the CEO and Chairman, received 500,000 stock options with an exercise price of $1.31 per share and a bonus of $480,000. Vice Chairman and Chief Technical Officer, Jane H. Hsiao, Ph.D., and Vice Chairman and President, Elias A. Zerhouni, M.D., each received 500,000 stock options and a bonus of $450,000. Executive Vice President Steven D. Rubin was awarded 437,500 stock options and a $400,000 bonus, while Senior Vice President and CFO Adam Logal received the same number of stock options and a $475,000 bonus. The options vest annually over four years and expire ten years from the grant date.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Opko Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-079098), on May 29, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}